AI assistant
Sending…
Hansa Biopharma — Major Shareholding Notification 2021
Apr 7, 2021
3057_iss_2021-04-07_4873874e-8f93-411a-a271-5aa7cfd2b643.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Hansa Biopharma AB
Holder
Handelsbanken Fonder AB
Instrument
| Instrument | Aktie SE0002148817 | ||||
|---|---|---|---|---|---|
| Before the transaction | |||||
| Shares | 2,223,483 | ||||
| Voting rights | 2,223,483 | ||||
| Transaction | |||||
| Date | 06/04/2021 | ||||
| Limit for number of votes | 5 % |
After the transaction
Quantity Shares 2,232,823 Directly held voting rights 2,232,823 Indirectly held voting rights 0
Percentage
Directly held shares 4.87 % Directly held voting rights 5.005 % Indirectly held voting rights 0 %
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||||
|---|---|---|---|---|---|
| Shares | 5.005 % | 2,232,823 | |||
| paragraph, line 2 | Instruments - FITA Ch. 4, section 2, first Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||||
| - Physically settled | |||||
| - Cash settled | |||||
| Total | 5.005 % | 2,232,823 | |||
| Group total holdings | |||||
| Voting rights | 2,232,823 | ||||
| Percentage of voting rights 5.005 | |||||
| Published | |||||
| 07/04/2021 16:04 | |||||
| Contact | |||||
| Name | Fredrik Alheden | ||||
| Phone | 087013503 | Email [email protected] |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Hansa Biopharma
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Capital/Financing Update
2026
May 19
Capital/Financing Update
2026
May 19
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Interim / Quarterly Report
2026
Apr 23
Interim / Quarterly Report
2026
Apr 23
Annual Report
2026
Mar 26
Annual Report
2026
Mar 26